Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong · Delayed Price · Currency is HKD 1.650
-0.010 (-0.60%)
Jul 18, 2025, 4:08 PM HKT
HKG:2633 Revenue
In the fiscal year ending March 31, 2025, Jacobson Pharma Corporation had annual revenue of 1.58B HKD with 7.43% growth. Jacobson Pharma Corporation had revenue of 766.90M in the half year ending March 31, 2025.
Revenue
1.58B
Revenue Growth
+7.43%
P/S Ratio
2.09
Revenue / Employee
901.60K
Employees
1,749
Market Cap
3.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.58B | 109.10M | 7.43% |
| Mar 31, 2024 | 1.47B | 200.20M | 15.79% |
| Mar 31, 2023 | 1.27B | -327.95M | -20.55% |
| Mar 31, 2022 | 1.60B | 149.63M | 10.35% |
| Mar 31, 2021 | 1.45B | -125.54M | -7.99% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |